Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.77
0.131.35%
Pre-Market: 5:38 PM EDT
Comments
Loading...
CervoMed (NASDAQ:CRVO) Stock, Analyst Ratings, Price Targets, Forecasts
CervoMed Inc has a consensus price target of $53.67 based on the ratings of 6 analysts. The high is $70 issued by Jones Trading on May 29, 2024. The low is $34 issued by D. Boral Capital on November 18, 2024. The 3 most-recent analyst ratings were released by D. Boral Capital, Chardan Capital, and Chardan Capital on November 18, 2024, November 14, 2024, and September 18, 2024, respectively. With an average price target of $48 between D. Boral Capital, Chardan Capital, and Chardan Capital, there's an implied 391.30% upside for CervoMed Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
Chardan Capital
Morgan Stanley
Canaccord Genuity
Brookline Capital
1calculated from analyst ratings
Analyst Ratings for CervoMed
Data brought to you by Benzinga APIs
FAQ
What is the target price for CervoMed (CRVO) stock?
The latest price target for CervoMed (NASDAQ:CRVO) was reported by D. Boral Capital on November 18, 2024. The analyst firm set a price target for $34.00 expecting CRVO to rise to within 12 months (a possible 248.00% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CervoMed (CRVO)?
The latest analyst rating for CervoMed (NASDAQ:CRVO) was provided by D. Boral Capital, and CervoMed initiated their buy rating.
When was the last upgrade for CervoMed (CRVO)?
There is no last upgrade for CervoMed
When was the last downgrade for CervoMed (CRVO)?
There is no last downgrade for CervoMed.
When is the next analyst rating going to be posted or updated for CervoMed (CRVO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CervoMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CervoMed was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.
Is the Analyst Rating CervoMed (CRVO) correct?
While ratings are subjective and will change, the latest CervoMed (CRVO) rating was a initiated with a price target of $0.00 to $34.00. The current price CervoMed (CRVO) is trading at is $9.77, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.